Publications by authors named "Jeffrey Rollo"

Claim this Profile
U
Utility of high density lipoprotein particle concentration in predicting future major adverse cardiovascular events among patients undergoing angiography.
Heidi T May, Jeffrey L Anderson, Deborah A Winegar, Jeffrey Rollo, Margery A Connelly

Clin Biochem· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shortened telomere length is associated with paroxysmal atrial fibrillation among cardiovascular patients enrolled in the Intermountain Heart Collaborative Study.
John F Carlquist, Stacey Knight, Richard M Cawthon, Viet T Le, T Jared Bunch, Jeffrey S Rollo

Heart Rhythm· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Possible Mechanistic Link Between the CYP2C19 Genotype, the Methadone Metabolite Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidene (EDDP), and Methadone-Induced Corrected QT Interval Prolongation in a Pilot Study.
John F Carlquist, David E Moody, Stacey Knight, Eric G Johnson, Wenfang B Fang, Jeffrey S Rollo

Mol Diagn Ther· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of dementia in relation to genetic variants at PITX2, ZFHX3, and ApoE ε4 in atrial fibrillation patients.
Jeffrey Rollo, Stacey Knight, Heidi T May, Jeffrey L Anderson, Joseph B Muhlestein

Pacing Clin Electrophysiol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery disease.
Jeffrey L Anderson, Stacey Knight, Heidi T May, Benjamin D Horne, Tami L Bair, Jeffrey S Rollo

Am J Cardiol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ABCB1 genes.
John F Carlquist, Stacey Knight, Benjamin D Horne, John A Huntinghouse, Jeffrey S Rollo

Thromb Haemost· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).
Jeffrey L Anderson, Benjamin D Horne, Scott M Stevens, Scott C Woller, Kent M Samuelson, Jeffrey S Rollo

Circulation· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis